Systemic Syndromes with Biomedicines

Since the introduction of biomedicines in human therapy, a number of systemic reactions have been more frequently reported as important adverse events following treatment. Some monoclonal antibodies, interleukins, receptor inhibitors, and growth factors may preferably induce acute, violent, early ev...

Descripción completa

Detalles Bibliográficos
Autor principal: Tridente, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121214/
http://dx.doi.org/10.1007/978-88-470-5313-7_3
_version_ 1783515152619929600
author Tridente, Giuseppe
author_facet Tridente, Giuseppe
author_sort Tridente, Giuseppe
collection PubMed
description Since the introduction of biomedicines in human therapy, a number of systemic reactions have been more frequently reported as important adverse events following treatment. Some monoclonal antibodies, interleukins, receptor inhibitors, and growth factors may preferably induce acute, violent, early events with an overall low frequency, but with serious and life-threatening capacity. .
format Online
Article
Text
id pubmed-7121214
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-71212142020-04-06 Systemic Syndromes with Biomedicines Tridente, Giuseppe Adverse Events with Biomedicines Article Since the introduction of biomedicines in human therapy, a number of systemic reactions have been more frequently reported as important adverse events following treatment. Some monoclonal antibodies, interleukins, receptor inhibitors, and growth factors may preferably induce acute, violent, early events with an overall low frequency, but with serious and life-threatening capacity. . 2013-07-12 /pmc/articles/PMC7121214/ http://dx.doi.org/10.1007/978-88-470-5313-7_3 Text en © Springer-Verlag Italia 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Tridente, Giuseppe
Systemic Syndromes with Biomedicines
title Systemic Syndromes with Biomedicines
title_full Systemic Syndromes with Biomedicines
title_fullStr Systemic Syndromes with Biomedicines
title_full_unstemmed Systemic Syndromes with Biomedicines
title_short Systemic Syndromes with Biomedicines
title_sort systemic syndromes with biomedicines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121214/
http://dx.doi.org/10.1007/978-88-470-5313-7_3
work_keys_str_mv AT tridentegiuseppe systemicsyndromeswithbiomedicines

Ejemplares similares